載入...
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
The myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal myeloid malignancies characterized by multilineage cytopenias, recurrent cytogenetic abnormalities, and risk of progression to acute myeloid leukemia (AML). AML, which can occur de novo as well as secondary to MDS, is chara...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4679081/ https://ncbi.nlm.nih.gov/pubmed/26463870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0165 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|